Abstract
In this introductory chapter the use of vaccines to intervene against virus-induced tumours will be discussed, the hepatitis B virus (HBV) and its causative role in primary hepatocellular carcinoma (PHC) being used as an example.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
London WT, Blumberg BS (1983) Hepatitis B and related viruses in chronic hepatitis, cirrhosis and hepatocellular carcinoma in man and animals. In: Cohen S, Soloway RD (eds) Chronic active liver disease. Churchill Livingstone, New York, p 147–170
Blumberg BS, London WT (1985) Guest Editorial. Hepatitis B virus and the prevention of primary cancer of the liver. Journal of the National Cancer Institute 74: 267–273
Blumberg BS, Larouze B, London WT, Werner B, Hesser JE, Millman I, Saimot G, Payet M (1975) The relation of infection with the hepatitis B agent to primary hepatic carcinoma. American Journal of Pathology 81: 669–682
Nishioka K, Hirayama T, Sekine T, Okochi K, Mayumi M, Sung J-L, Liu C-H, Lin T-M (1973) Australia antigen and hepatocellular carcinoma. GANN Monograph on Cancer Research 14: 167–175
Blumberg BS, Millman I (1972) Patent Vaccine against viral hepatitis and process. Submitted October 8, 1969. US Patent Office No 3,636, 191, 1972
Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, Sadovsky R, Morrison JM, Kellner A (1980) Hepatitis B vaccine: Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. New England Journal of Medicine 303: 833–841
Kessler H, Chase R, Harris A, Jensen D, Levin S (1985) HTLV-III antibodies after hepatitis B vaccination. Lancet 1: 1506–1507
Poisz B, Tomar R, Lehr B, Moore J (1984) Hepatitis B vaccine: evidence confirming lack of AIDS transmission. Morbidity and Mortality Weekly Report 33: 685–687
Kirschbaum A, Salomon A, Parker E, Abarca V, Contreras L, Chomali M, Dinator R, Escobar L, Fabre V, Gelman M, Gutierrez V, Hazbun M, Murillo V, Opazo A, Riveros T, SammanM (1985) Recommendations for protection against viral hepatitis. Recommendation of the Immunization Practices Advisory Committee (ACIP). Morbidity and Mortality Weekly Report 34: 314–335
Beasley RP, Lin C-C, Hwang L-Y, Chien C-S (1981) Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22,707 men in Taiwan. Lancet 2: 1129–1133
Marinier E, Barrois V, Larouze B, London WT, Cofer A, Diakhate L, Blumberg BS (1985) Lack of perinatal transmission of hepatitis B virus infection in Senegal, West Africa. Journal of Pediatrics 106: 843–849
Urban MK, O’Connell AP, London WT (1985) Sequence of events in natural infection of Pekin duck embryos with duck hepatitis B virus. Journal of Virology 55: 16–22
Tang Z, Yang B, Tang C, Yu Y, Lin Z, Weng H (1980) Evaluation of population screening for hepatocellular carcinoma. Chinese Medical Journal 93: 795–799
Drew JS, London WT, Lustbader ED, Hesser JE, Blumberg BS (1978) Hepatitis B virus and sex ratio of offspring. Science 201: 687–692
Drew J, London WT, Blumberg BS, Serjeantson S (1982) Hepatitis B virus and sex ratio on Kar Kar Island. Human Biology 54: 123–135
London WT, Stevens RG, Shofer FS, Drew JS, Brunhofer JE, Blumberg BS (1982) Effects of hepatitis B virus on the mortality, fertility and sex ratio of human populations. In: Szmuness W, Alter HJ, Maynard JE (eds) Viral hepatitis. Franklin Institute Press, Philadelphia, p 195–202
Drew JS, Blumberg BS, Robert-Lamblin J (1986) Hepatitis B virus and sex ratio of offspring in East Greenland. Human Biology 58: 115–120
London WT, Drew JS (1977) Sex differences in response to hepatitis B infection among patients receiving chronic dialysis treatment. Proceedings of the National Academy of Sciences USA 74: 2561–2563
Editor information
Editors and Affiliations
Copyright information
© 1986 The Leukaemia Research Fund
About this chapter
Cite this chapter
Blumberg, B.S. (1986). Hepatitis B Virus and Primary Cancer of the Liver. In: Goldman, J.M., Epstein, M.A. (eds) Vaccine Intervention Against Virus-Induced Tumours. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-08243-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-349-08243-8_1
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-08245-2
Online ISBN: 978-1-349-08243-8
eBook Packages: MedicineMedicine (R0)